Background: Cell transplantation has been viewed as a promising strategy for end-stage heart failure, but long-term follow-up results are lacking.
Case Report: In December 2002 we began transplanting autologous skeletal myoblasts in one patient because of serious coronary heart disease. Here, we present the 9-year follow-up results of this patient. No ventricular tachyarrhythmias were detected after treatment. The patient had another myocardial infarction in April 2012 and was treated successful with PCI.
Conclusions: Autologous skeletal myoblast transplantation with bypass surgery is associated with improvement in cardiac function and lack of adverse effects in long-term follow-up, making it a promising therapy for patients with heart failure.

Keywords: skeletal myoblast, cellular transplantation, ischemic heart disease, Heart Failure - drug therapy